Intrinsic Value of S&P & Nasdaq Contact Us

Anebulo Pharmaceuticals, Inc. ANEB OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+1100%

Stock Statistics — ANEB

Anebulo Pharmaceuticals, Inc. (ANEB) has a market capitalization of $20.39M and trades at $0.50. The 52-week range is 0.3-3.42.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-0.25.

The stock has a beta of -1.62, operates in the Healthcare sector.

Trading Data
Current Price$0.50
52-Week Range0.3-3.42
Volume273
Avg Volume (30D)74.54K
Market Cap$20.39M
Beta (1Y)-1.62
Company
IPO Date2021-05-07
Employees2
CEORichard Anthony Cunningham
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS0345691036
CUSIP034569103
Income (Latest Year)
EBITDA$-8.1M
Operating Income$-9.22M
Net Income$-8.48M
EPS$-0.25
EPS Diluted$-0.25
Shares Outstanding$33.82M
Balance Sheet (Latest Year)
Total Assets$12.15M
Current Assets$11.96M
Cash & ST Investments$11.63M
Total Liabilities$487.69K
Net Debt$-11.63M
Total Equity$11.66M
Valuation Ratios
P/E Ratio-2
P/B Ratio1.75
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message